Introduction
GLP-1 receptor agonists are best known for their roles in metabolic research — glycaemic control, weight management, and cardiovascular protection. However, a rapidly expanding body of preclinical research has identified the GLP-1 receptor as a significant target in the central nervous system, with implications for neurodegeneration, neuroinflammation, and cognitive function. GLP-1 receptors are expressed throughout the brain, including in the hippocampus, cortex, hypothalamus, and substantia nigra — regions critically involved in memory, mood, and motor control.
For research and laboratory use only. Not intended for human or veterinary administration.
GLP-1 Receptor Signalling in the Brain
Central GLP-1 receptor activation triggers cAMP-mediated signalling cascades that promote neuronal survival, reduce oxidative stress, and suppress neuroinflammatory pathways including NF-κB and NLRP3 inflammasome activation. GLP-1 also crosses the blood-brain barrier, and peripheral GLP-1 receptor agonists have been shown to exert central effects in preclinical models, likely through both direct CNS penetration and vagal afferent signalling.
Parkinson's Disease Research
One of the most active areas of GLP-1 neuroprotection research involves Parkinson's disease models. GLP-1 receptor agonists including Semaglutide and Liraglutide have demonstrated neuroprotective effects in MPTP and 6-OHDA rodent models of dopaminergic neurodegeneration. Proposed mechanisms include reduction of microglial activation, suppression of α-synuclein aggregation, and promotion of mitochondrial biogenesis in dopaminergic neurons. Epidemiological data from diabetic patient cohorts has further fuelled research interest in this area.
Alzheimer's Disease Research
GLP-1 receptor agonists have been studied in multiple Alzheimer's disease models for their ability to reduce amyloid-β plaque burden, decrease tau hyperphosphorylation, and improve synaptic plasticity. Liraglutide in particular has been extensively studied in APP/PS1 transgenic mouse models, demonstrating reductions in amyloid deposition and improvements in spatial memory tasks. The insulin-sensitising properties of GLP-1 agonists are also of relevance given the growing evidence for insulin resistance as a contributor to Alzheimer's pathology.
Neuroinflammation Models
Chronic neuroinflammation — characterised by microglial activation and elevated pro-inflammatory cytokines (TNF-α, IL-1β, IL-6) in the CNS — is a common feature of neurodegenerative disease. GLP-1 receptor agonists have demonstrated consistent anti-neuroinflammatory effects across multiple preclinical models, suppressing microglial activation and reducing CNS cytokine burden. This positions them as research tools of broad relevance beyond any single disease model.
Stroke and Ischaemic Brain Injury
GLP-1 receptor agonists have been studied in models of cerebral ischaemia for their ability to reduce infarct volume, promote neuronal survival, and improve functional recovery. Proposed mechanisms include reduction of excitotoxicity, suppression of apoptotic cascades, and promotion of BDNF expression in peri-infarct tissue.
Depression and Anxiety Models
Emerging preclinical research has explored GLP-1 receptor agonism in models of depression and anxiety, with findings suggesting modulation of the HPA axis, reduction of neuroinflammatory markers associated with depressive phenotypes, and potential interactions with dopaminergic reward circuitry.
Research Applications
- Parkinson's disease and dopaminergic neurodegeneration models
- Alzheimer's disease and amyloid/tau pathology research
- Neuroinflammation and microglial activation models
- Cerebral ischaemia and stroke recovery research
- Depression, anxiety, and HPA axis modulation
- Blood-brain barrier penetration and CNS drug delivery research
Storage and Handling
Store lyophilised GLP-1 peptides at −20°C. Reconstitute with bacteriostatic water. Once reconstituted, store at 2–8°C and use within 28 days. Avoid repeated freeze-thaw cycles.
All products supplied by Vanta Labs are intended strictly for laboratory and research purposes.